---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-021615"
form_type: "8-K"
ticker: "PLSE"
cik: "0001625101"
company_name: "PULSE BIOSCIENCES, INC."
filed_at: "2024-06-28T23:59:59+00:00"
generated_at: "2026-06-01T00:36:41.814842+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Pulse Biosciences rights offering oversubscribed, raises $60M; Duggan to hold ~72%

## Summary
- Offering oversubscribed at 138%, receiving over $83M in subscriptions vs $60M limit.
- Expected gross proceeds of $60M from sale of ~6M units at $10/unit.
- Executive Chairman Robert Duggan subscribed for ~5M units, boosting his ownership to ~72%.
- Warrants could generate up to $66M additional proceeds if exercised; exercise price $11/share.
- Units consist of one share and two warrants; warrants expire in five years with redemption conditions.

## SEC filing metadata
- accession: 0001437749-24-021615
- form_type: 8-K
- ticker: PLSE
- cik: 0001625101
- company_name: PULSE BIOSCIENCES, INC.
- filed_at: 2024-06-28T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625101/000143774924021615/0001437749-24-021615-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625101/000143774924021615/plse20240627_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-021615
- JSON: https://secwatch.observer/filing/0001437749-24-021615.json
- Plain text: https://secwatch.observer/filing/0001437749-24-021615.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.